Artio Medical this week announced it received FDA clearance for its Solus Gold embolization device for peripheral vascular occlusion. Solus Gold is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. The delivery system uses flexibility and push ability to enable physicians to navigate tortuous … [Read more...] about Artio Medical wins FDA clearance for Solus Gold embolization device
Catheters
FDA clears Cerus Endovascular 027 microcatheters
Cerus Endovascular this week announced the FDA 510(k) clearance of its 027 microcatheters. Fremont, California-based Cerus Endocascular's new microcatheters are available in two lengths. The company expects to submit for CE mark approval under the EU new Medical Devices Regulation later this year. A limited market release of the 027 … [Read more...] about FDA clears Cerus Endovascular 027 microcatheters
This tentacle-like magnetic robot could navigate the lungs
Engineers at the University of Leeds have developed a magnetic tentacle robot to pass through the narrow tubes of the lungs. Scientists and engineers at the university made a proof of concept for a robotic device that can reach the smallest bronchial tubes to take tissue samples and deliver cancer therapy. The tentacle robot has a diameter of … [Read more...] about This tentacle-like magnetic robot could navigate the lungs
Cathi launches Cathis RHC 2 right heart catheter simulator
German-based endovascular simulator company Cathi recently announced that it launched its Cathis RHC 2 right heart catheter simulator. The company developed Cathis RHC 2 in close consultation with the Cologne Cardiovascular Research Center in Germany. It has all features of the first iteration of the device with added benefits of wire-assisted … [Read more...] about Cathi launches Cathis RHC 2 right heart catheter simulator
Cardiovascular Systems treats first patients using Propel pVAD
Cardiovascular Systems today announced the first in-human procedures using its Propel percutaneous ventricular assist device. The first patients were treated at Piedmont Heart Institute and Cardiovascular Services in Tbilisi, Georgia by Dr. David Kandzari. The St. Paul, Minnesota-based company reported that Propel performed as intended and … [Read more...] about Cardiovascular Systems treats first patients using Propel pVAD
Inari Medical to bring in up to $186.3M in stock offering
Inari Medical (Nasdaq:NARI) announced that it priced an underwritten public offering worth up to $186.3 million in proceeds. Irvine, California-based Inari Medical’s offering includes 2 million shares of its common stock at a public offering price of $81 per share before underwriting discounts and commissions. In addition, the company granted … [Read more...] about Inari Medical to bring in up to $186.3M in stock offering
NeoChord appoints executive chair to lead early feasibility study of transcatheter mitral chordal repair device
NeoChord appointed Dr. Martin Leon as executive chair of the company's U.S. early feasibility study of its Transcatheter Nexus system. Leon will be responsible for overseeing and leading the company's initiatives to advance its U.S. regulatory strategy for the Nexus system. He will also guide the company's overall global regulatory strategy as … [Read more...] about NeoChord appoints executive chair to lead early feasibility study of transcatheter mitral chordal repair device
Stereotaxis opens new headquarters in St. Louis
Surgical robotics company Stereotaxis (NYSE: STXS) is holding a grand opening today for its 45,000 ft² headquarters facility in downtown St. Louis. The new headquarters is located in the renovated historic Globe Building in St. Louis’s growing Downtown North Urban Insight District. It's an all-in-one facility housing research and development, … [Read more...] about Stereotaxis opens new headquarters in St. Louis
Silk Road Medical grows sales 33% in Q4
Silk Road Medical (NSDQ:SILK) posted fourth-quarter results that beat the revenue consensus on Wall Street and missed on earnings estimates. The Sunnyvale, California-based stroke treatment tech company reported losses of -$14.7 million, or -42¢ per share, on sales of $28.3 million for the three months ended Dec. 31, 2021, for a bottom-line gain … [Read more...] about Silk Road Medical grows sales 33% in Q4
Cardiovascular Systems, Innova Vascular partner to develop thrombectomy devices
Cardiovascular Systems (NSDQ:CSII) announced that it has partnered with Innova Vascular to develop a full line of thrombectomy devices. Under the terms of the agreement, Cardiovascular Systems (St. Paul, Minnesota) will provide financing to Innova (Irvine, California) to develop thrombectomy devices to remove blood clots from arteries and veins. … [Read more...] about Cardiovascular Systems, Innova Vascular partner to develop thrombectomy devices